Cleared Traditional

K945250 - TRIMPORT

K945250 is an FDA 510(k) clearance for TRIMPORT, manufactured by Gerard Medical Enterprises, Inc.. The device is a Class 2 General Hospital device with product code LJT cleared through the Traditional 510(k) pathway after a 130-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1995
Decision
130d
Days
Class 2
Risk

K945250 is an FDA 510(k) clearance for the TRIMPORT. Classified as Port & Catheter, Implanted, Subcutaneous, Intravascular (product code LJT), Class II - Special Controls.

Submitted by Gerard Medical Enterprises, Inc. (Charlton, US). The FDA issued a Cleared decision on March 7, 1995 after a review of 130 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5965 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Gerard Medical Enterprises, Inc. devices

FDA 510(k) Submission Details - K945250

510(k) Number K945250 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 28, 1994
Decision Date March 07, 1995
Days to Decision 130 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
1d slower than avg
Panel avg: 129d · This submission: 130d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LJT Device Classification - Class 2, Special Controls

Product Code LJT Port & Catheter, Implanted, Subcutaneous, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5965
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LJT Port & Catheter, Implanted, Subcutaneous, Intravascular

All 236
Devices cleared under the same product code (LJT) and FDA review panel - the closest regulatory comparables to K945250.
CELSITE(TM) DUAL VENOUS SYSTEM
K945551 · B. Braun of America, Inc. · Apr 1995
A2 DETACHED DUAL PORT SYSTEM
K950212 · Therex Corp. · Apr 1995
1.0MM 1.8MMO.D. POLYURETHANE DETACHED MODEL
K950131 · Therex Corp. · Mar 1995
STRATO MEDICAL LIFEPORT LPS 7515
K942848 · Strato Medical Corp. · Feb 1995
STRATO MEDICAL INFUSE-A-PORT/INFUSE-A-KIT PERIPORT PERIPHERAL ACCESS SYSTEM
K934518 · Strato Medical Corp. · Jan 1995
CATHLINK 20 TITANIUM PORT W/ATT. POLYURETHANE CATH
K926139 · Bard Access Systems, Inc. · Jan 1995